Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 2 , Pages 245-259, April 2009

ACTH-independent macronodular adrenal hyperplasia

  • André Lacroix, MD (Professor of Medicine)

      Affiliations

    • Corresponding Author InformationTel.: +1 514 890 8000x14930; Fax: +1 514 412 7128.

Division of Endocrinology, Department of Medicine, Centre hospitalier de l'Université de Montréal (CHUM), Hôtel-Dieu du CHUM, 3840 Saint-Urbain street, Montréal, Québec, H2W 1T8 Canada

Adrenocorticotropic hormone- (ACTH-)independent macronodular adrenal hyperplasia (AIMAH) is an infrequent cause of Cushing's syndrome (CS). AIMAH presents as incidental radiological finding or with subclinical or overt CS, occasionally with secretion of mineralocorticoids or sex steroids. The pathophysiology of this entity is heterogeneous. The aberrant adrenal expression and function of one or several G-protein-coupled receptors can lead to cell proliferation and abnormal regulation of steroidogenesis. In several familial cases of AIMAH, specific aberrant hormone receptors are functional in the adrenal of affected members. Additional somatic genetic events related to cell cycle regulation, adhesion and transcription factors occur in addition in the various nodules over time. Other mechanisms, such as Gsp or ACTH receptor mutations and paracrine adrenal hormonal secretion, have been rarely identified in other cases of AIMAH. The identification of aberrant receptors can offer a specific pharmacological approach to prevent progression and control abnormal steroidogenesis; alternatively, unilateral or bilateral adrenalectomy becomes the treatment of choice.

Keywords: ACTH-independent macronodular adrenal hyperplasia (AIMAH), aberrant adrenal G-protein coupled receptors, Cushing's syndrome, familial forms

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-690X(08)00118-8

doi:10.1016/j.beem.2008.10.011

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 2 , Pages 245-259, April 2009